Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Apira Science, Inc. Receives Approval to Sell and Distribute its iGrow® Hair Growth System Throughout Mexico


Print article Print article
© Business Wire 2014
2014-02-11 16:02:03 -

Apira Science, Inc. : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. today announced that it has received approval from the Federal Commission for Protection against Health Risks (COFEPRIS) : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. to sell and distribute the iGrow ® Hair Growth System throughout Mexico, an emerging and rapidly growing aesthetic market. As the 40 th international market to receive the low-level laser therapy : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. (LLLT) hair growth device, Mexico represents the latest step in Apira’s continuing global expansion to meet worldwide demand for a simple, effective, and safe solution to hair loss.

The current market for LLLT products is more than $1.6 billion and is expected to reach $2.5 billion in the next five years. Mexico joins a growing list of countries

where the iGrow is now, or will soon be available, including all 28 European Union nations : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Feur .. as well as Canada, Hong Kong, China, Thailand, United Arab Emirates, Singapore, Malaysia, Peru, Taiwan, Vietnam, and Turkey.

“Genetic-based hair thinning and loss (pattern baldness) is a widespread condition that affects men and women of all ages and nationalities,” said Nicholas Brox, president and CEO of Apira. “With the introduction of the iGrow to the Mexican marketplace, individuals suffering from pattern baldness (Androgenetic Alopecia) will now be able to address and remedy hair thinning and loss effectively and conveniently, in the comfort of their own homes.”

The iGrow Hair Growth System is an innovative, safe, and effective hands-free LLLT hair growth device cleared by the FDA for at-home use.
Its patented red light technology, which consists of a highly productive combination of red laser and LED diodes, re-energizes cells at the follicle level, effectively regrowing thicker, fuller, and healthier hair. In clinical studies, the iGrow increased hair growth 39 percent after 16 weeks of therapy, and nearly doubled total hair growth 10 weeks faster than hand-held laser combs and brushes.

For more information on the iGrow Hair Growth System, visit www.igrowlaser.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. .


About Apira Science, Inc.

Apira Science, Inc. has pioneered low-level light therapy (LLLT) for over a decade. Its iGrow Hair Growth Platform draws on its expertise and innovations in the application of LLLT to deliver a simple, safe, and effective hair growth treatment.

iGrow is a registered trademark of Apira Science, Inc.



Press Resources

iGrow website: www.igrowlaser.com : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. Product images: goo.gl/bJhkPT : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fgoo ..

" title="http://cts.businesswire.com/ct/CT?id=bwnews&sty=20140211005132r1&sid=16929&distro=ftp\"/>" target="_blank" rel="nofollow">cts.businesswire.com/ct/CT?id=bwnews&sty=20140211005132r1&am ..

Gregory

FCA : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. Alicia Buonanno, 610-228-2096 Alicia@gregoryfca.com : mailto:Alicia@gregoryfca.com


Author:
Hossam Abdel-Kader
e-mail
Web: www.pr-inside.com/
Phone: +43 1 9582319

Disclaimer: (c) 2014 Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com